Market Name: Wellbutrin

Generic Name: Bupropion hydrochloride

Wellbutrin, an anti-depressant, has been shown to cause an increase in suicidal feelings and behavior in children and adolescents. While the FDA acknowledges that depression and other psychiatric disorders themselves are associated with increased risk of suicidal behavior, studies have shown that anti-depressants such as Wellbutrin have the potential to greatly increase this risk.

A black box warning detailing this risk was added to Wellbutrin’s prescribing information by the FDA in February of 2006.

Black Box Warning Date: February 2006

FDA Link: Wellbutrin